Scopus BioPharma Provides Update Following Annual Meeting of Stockholders Jan 10, 2022 08:30AM
Scopus BioPharma Provides Update Following Annual Meeting of Stockholders Jan 10, 2022 08:30AM
Scopus BioPharma Issues Open Letter to Stockholders Detailing Morris Laster’s Campaign Against the Company Dec 17, 2021 08:00AM
Scopus BioPharma Sends Letter Urging Stockholders to Vote “FOR ALL” of the Company’s Director Nominees on the WHITE Proxy Card Dec 7, 2021 08:30AM
Scopus BioPharma Inc. (SCPS) Announces 3M Share Private Placement at $3.25/sh Nov 22, 2021 08:03AM


Nov 22, 2021 08:00AM Scopus BioPharma Announces $9.75 Million Private Placement Priced At-The-Market
Oct 8, 2021 05:30PM Scopus BioPharma Announces Adjournment of Annual Meeting of Stockholders
Oct 5, 2021 08:45AM Scopus BioPharma to Present at the LD Micro Main Event
Oct 1, 2021 07:00AM Scopus BioPharma to Present at MicroCap Rodeo’s Fall Harvest Best Ideas Conference
Sep 29, 2021 08:30AM Scopus BioPharma's Subsidiary — Duet Therapeutics — Announces Release of Preclinical Data Being Presented at 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Sep 28, 2021 09:15AM Scopus BioPharma’s Subsidiary Duet Therapeutics Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Sep 28, 2021 06:30AM Scopus BioPharma’s Subsidiary — Duet Therapeutics — Set to Release Scientific Data During the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Sep 28, 2021 06:00AM Scopus BioPharma to Adjourn 2021 Annual Meeting of Stockholders
Sep 23, 2021 08:30AM Scopus BioPharma to Present at the Benzinga Healthcare Small Cap Conference
Sep 22, 2021 08:30AM Scopus BioPharma's Subsidiary — Duet Therapeutics — to Present at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society
Sep 21, 2021 09:04AM Scopus BioPharma Inc. (SCPS) Announces China National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platform
Sep 21, 2021 09:00AM China National Intellectual Property Administration Grants New Patent Covering DUET-02, One of Three Key CpG-STAT3 Inhibitors Comprising the Duet Platform
Sep 14, 2021 09:00AM Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointments of John Rossi, Ph.D. and Nagy Habib, Ch.M., F.R.C.S. to the Scientific Advisory Board
Sep 9, 2021 08:00AM Scopus BioPharma to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Sep 7, 2021 09:15AM Scopus BioPharma’s Subsidiary — Duet Therapeutics — Announces Appointment of Marcin Kortylewski, Ph.D. as Senior Scientific Advisor
Sep 3, 2021 09:25AM Scopus BioPharma’s Subsidiary — Duet Therapeutics — to Present at the 14th Annual RNA Consortium Meeting
Sep 2, 2021 09:15AM Scopus BioPharma Launches Duet Therapeutics
Jul 12, 2021 08:30AM Scopus BioPharma Announces New Management Appointment Following Acquisition of Leading Immunotherapy Company
Jun 30, 2021 09:30AM Scopus BioPharma Expands Immunotherapy Pipeline with Acquisition of Olimmune
May 31, 2021 08:30PM Scopus BioPharma Announces New Date for 2021 Annual Meeting of Stockholders
May 26, 2021 07:30PM Scopus BioPharma to Reschedule 2021 Annual Meeting of Shareholders
May 24, 2021 09:30AM Scopus BioPharma (SCPS) Announces FDA Approval of IND Application for Lead Drug Candidate
May 24, 2021 09:30AM Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
Apr 26, 2021 09:25AM Scopus BioPharma (SCPS) Announces IND Submission to FDA for Lead Drug Candidate
Apr 26, 2021 09:25AM Scopus BioPharma Announces IND Submission to FDA for Lead Drug Candidate
Mar 15, 2021 07:04AM Scopus BioPharma Inc. (SCPS) Finalizes Arrangements for Submission of IND Package
Mar 15, 2021 07:00AM Scopus BioPharma Finalizes Arrangements for Submission of IND Package
Jan 19, 2021 07:00AM Scopus BioPharma Announces Completion of Clinical Lot Manufacture
Dec 29, 2020 04:00AM Scopus BioPharma Announces Appointment of Additional Directors